OBI Pharma, Inc.

OBI Pharma, Inc.verified

4174.TWO

Price:

$27.65

Market Cap:

$7.27B

OBI Pharma, Inc., a biopharma company, develops and licenses novel therapeutic agents for unmet medical needs against cancer in Taiwan and internationally. It offers Adagloxad Simolenin (OBI-822), a breast cancer active immunity anti-cancer drug for generating antibody against tumor carbohydrate antigen Globo H; OBI-833, an immunity anti-cancer drug for the treatment of lung cancer; OBI-866 SSEA-4, an active immune-oncology drug; OBI-888, a passive immunotherapy monoclonal antibody designed for targeting Globo H; OBI-999, an antibody drug conjugate; OBI-3424, a micromolecule chemotherapy prodrug; and OBI-858, a botulinum toxin, as well as OBI-898 and OBI-998 drugs. The company was founded in...[Read more]

Industry

Biotechnology

IPO Date

2012-12-12

Stock Exchange

TWO

Ticker

4174.TWO

The Enterprise Value as of December 2025 (TTM) for OBI Pharma, Inc. (4174.TWO) is 6.67B

According to OBI Pharma, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 6.67B. This represents a change of -49.92% compared to the average of 13.33B of the last 4 quarters.

OBI Pharma, Inc. (4174.TWO) Historical Enterprise Value (quarterly & annually)

How has 4174.TWO Enterprise Value performed in the past?

The mean historical Enterprise Value of OBI Pharma, Inc. over the last ten years is 30.26B. The current 6.67B Enterprise Value has changed 2.11% with respect to the historical average. Over the past ten years (40 quarters), 4174.TWO's Enterprise Value was at its highest in in the December 2015 quarter at 106.79B. The Enterprise Value was at its lowest in in the June 2025 quarter at 8.02B.

Quarterly (TTM)
Annual

Average

30.26B

Median

21.51B

Minimum

10.76B

Maximum

105.98B

OBI Pharma, Inc. (4174.TWO) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of OBI Pharma, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 95.52%

Maximum Annual Enterprise Value = 105.98B

Minimum Annual Increase = -55.68%

Minimum Annual Enterprise Value = 10.76B

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202412.44B-19.38%
202315.43B43.32%
202210.76B-47.04%
202120.33B-16.49%
202024.34B17.06%
201920.79B-6.46%
201822.23B-4.56%
201723.29B-50.42%
201646.97B-55.68%
2015105.98B95.52%

OBI Pharma, Inc. (4174.TWO) Average Enterprise Value

How has 4174.TWO Enterprise Value performed in the past?

The current Enterprise Value of OBI Pharma, Inc. (4174.TWO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

12.88B

5-year avg

16.66B

10-year avg

30.26B

OBI Pharma, Inc. (4174.TWO) Enterprise Value vs. Peers

How is 4174.TWO’s Enterprise Value compared to its peers?

OBI Pharma, Inc.’s Enterprise Value is greater than Formosa Pharmaceuticals, Inc. (3.82B), less than TaiGen Biopharmaceuticals Holdings Limited (8.85B), greater than Pharmosa Biopharm Inc. (6.54B), greater than BRIM Biotechnology, Inc. (3.11B), less than Mycenax Biotech Inc. (7.42B), greater than CHO Pharma, Inc. (5.87B), greater than Savior Lifetec Corporation (4.26B), greater than Sinphar Pharmaceutical Co.,Ltd. (6.58B), greater than Panion & Bf Biotech Inc. (5.75B), less than PharmaEngine, Inc. (7.72B),

Build a custom stock screener for OBI Pharma, Inc. (4174.TWO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like OBI Pharma, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

OBI Pharma, Inc. (4174.TWO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like OBI Pharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is OBI Pharma, Inc.'s Enterprise Value?

What is the highest Enterprise Value for OBI Pharma, Inc. (4174.TWO)?

What is the 3-year average Enterprise Value for OBI Pharma, Inc. (4174.TWO)?

What is the 5-year average Enterprise Value for OBI Pharma, Inc. (4174.TWO)?

How does the current Enterprise Value for OBI Pharma, Inc. (4174.TWO) compare to its historical average?